Market Cap
A$236.4 Million
AUD as of July 1, 2024
US$157.4 Million
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$233.33 B |
Boston Scientific Corporation
|
$154.34 B |
Stryker
|
$151.06 B |
Medtronic
|
$113.25 B |
Edwards Lifesciences Corporation
|
$45.05 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
New Zealand
languages
Healthcare
languages
Medical Devices
New Zealand Healthcare
New Zealand Medical Devices
Aroa Biosurgery Limited has the following listings and related stock indices.
Stock: ASX: ARX
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.